4-[6-bromo-3-[2-[(3S,4R)-3,4-dihydroxypiperidin-1-yl]acetyl]-2-methylpyrrolo[3,2-b]pyridin-1-yl]benzonitrile
C22H21BrN4O3 — CID 118085816
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[6-bromo-3-[2-[(3S,4R)-3,4-dihydroxypiperidin-1-yl]acetyl]-2-methylpyrrolo[3,2-b]pyridin-1-yl]benzonitrile
4-[6-bromo-3-[2-[(3S,4R)-3,4-dihydroxypiperidin-1-yl]acetyl]-2-methylpyrrolo[3,2-b]pyridin-1-yl]benzonitrile (PubChem CID 118085816) has the molecular formula C22H21BrN4O3 and a molecular weight of 469.34 g/mol. Its IUPAC name is 4-[6-bromo-3-[2-[(3S,4R)-3,4-dihydroxypiperidin-1-yl]acetyl]-2-methylpyrrolo[3,2-b]pyridin-1-yl]benzonitrile.
Molecular Properties
| Compound Name | 4-[6-bromo-3-[2-[(3S,4R)-3,4-dihydroxypiperidin-1-yl]acetyl]-2-methylpyrrolo[3,2-b]pyridin-1-yl]benzonitrile |
|---|---|
| PubChem CID | 118085816 |
| Molecular Formula | C22H21BrN4O3 |
| Molecular Weight | 469.34 g/mol |
| Exact Mass | 468.08 |
| IUPAC Name | 4-[6-bromo-3-[2-[(3S,4R)-3,4-dihydroxypiperidin-1-yl]acetyl]-2-methylpyrrolo[3,2-b]pyridin-1-yl]benzonitrile |
| SMILES | Cc1c(C(=O)CN2CC[C@@H](O)[C@@H](O)C2)c2ncc(Br)cc2n1-c1ccc(C#N)cc1 |
| InChI | InChI=1S/C22H21BrN4O3/c1-13-21(20(30)12-26-7-6-18(28)19(29)11-26)22-17(8-15(23)10-25-22)27(13)16-4-2-14(9-24)3-5-16/h2-5,8,10,18-19,28-29H,6-7,11-12H2,1H3/t18-,19+/m1/s1 |
| InChIKey | HVZDHJOKOLPEQT-MOPGFXCFSA-N |
| XLogP | 2.58 |
| TPSA | 102.38 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 469.34 |
| LogP ≤ 5 | 2.58 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118085816 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.